{"id":"392f1e48-072e-49a7-888a-2ba984507dca","kind":"news","code":"392f1e48-072e-49a7-888a-2ba984507dca","name":"Multiply Labs raises USD 75 million in Series B funding to automate pharmaceutical manufacturing with robots","nameBasis":"translated-title","summary":"On 2026/10/8, AIPressRoom reported that Multiply Labs raised USD 75 million in Series B funding, led by Patrick Soon-Shiong and NantWorks. It uses robotic systems to automate biologic drug production, improving pharmaceutical manufacturing efficiency and quality consistency.","description":"","country":null,"category":null,"originalName":"Multiply Labs完成7500万美元B轮融资，机器人制药生产自动化","eventDate":"2026-10-08T00:00:00.000Z","website":"https://aipressroom.com/multiply-labs-75m-robotic-manufacturing/","sourceUpdatedAt":"2026-10-15T06:00:19.301Z","englishUpdatedAt":"2026-10-15T22:53:07.222Z","reviewedAt":"2026-10-15T22:53:07.222Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"c6988d1531ff6d2720632275ed09a90c79a73b7e6122e2d8c027c8a7569f68ae","companyId":"c2752964-aed9-4c93-85cd-369af262ef2d","foundedYear":null,"logoUrl":null,"originalText":"2026年10月8日，据AIPressRoom报道，Multiply Labs完成7500万美元B轮融资，由Patrick Soon-Shiong与NantWorks领投。公司用机器人系统自动化生物药生产，提高制药制造效率与质量一致性。","sources":[{"url":"https://aipressroom.com/multiply-labs-75m-robotic-manufacturing/","publishedOn":"2026-10-08T00:00:00.000Z"}],"related":[{"id":"c2752964-aed9-4c93-85cd-369af262ef2d","kind":"companies","code":"UB-C8995","name":"Multiply Labs","nameBasis":"source-english","summary":"Robotic pharmaceutical production company automating biologics manufacturing.","description":"","country":null,"category":null,"originalName":"Multiply Labs","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-10T00:00:00.000Z","englishUpdatedAt":"2026-10-15T19:41:55.074Z","reviewedAt":"2026-10-15T19:41:55.074Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"c61d086528013de665edcfab5ae9a60f17a6cf909ea5f6b650441662a3d92d54","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/multiply-labs"},{"id":"91e0c159-34d9-4b78-8e8f-3b4a9c09da8a","kind":"institutions","code":"UB-I2465","name":"NantWorks","nameBasis":"original-brand","summary":"NantWorks, a corporate investment entity undertaking strategic investments.","description":"NantWorks, a corporate investment entity undertaking strategic investments.","country":null,"category":null,"originalName":"NantWorks","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:27.911Z","englishUpdatedAt":"2026-10-15T17:35:39.399Z","reviewedAt":"2026-10-15T17:35:39.399Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"9c34d3796e9091b9a16f489dcf28859769707cff75d2bb9c070a7a54b9888578","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nantworks"},{"id":"ecdc4718-5afc-4772-9076-aa6de4b0d614","kind":"institutions","code":"UB-I2469","name":"Patrick Soon-Shiong","nameBasis":"original-brand","summary":"Patrick Soon-Shiong, an individual investor active in early-stage technology venture investment.","description":"Patrick Soon-Shiong, an individual investor active in early-stage technology venture investment.","country":null,"category":null,"originalName":"Patrick Soon-Shiong","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:27.935Z","englishUpdatedAt":"2026-10-15T17:35:39.953Z","reviewedAt":"2026-10-15T17:35:39.953Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"345a0aff5dbedd258740df2349ad8ef116c0727804377b26b9c23df188f83d5f","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/patrick-soon-shiong"}],"path":"/news/392f1e48-072e-49a7-888a-2ba984507dca","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Multiply Labs","path":"/companies/multiply-labs"}},"canonical":"https://uniquebase.ai/news/392f1e48-072e-49a7-888a-2ba984507dca"}